Morgan Stanley’s Newmark Group NMRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $29.5M | Buy |
1,954,295
+196,773
| +11% | +$3M | ﹤0.01% | 2739 |
|
|
2026
Q1 | $26.3M | Sell |
1,757,522
-233,982
| -12% | -$3.69M | ﹤0.01% | 2684 |
|
|
2025
Q4 | $34.5M | Buy |
1,991,504
+203,394
| +11% | +$3.56M | ﹤0.01% | 2434 |
|
|
2025
Q3 | $33.3M | Buy |
1,788,110
+185,667
| +12% | +$3.01M | ﹤0.01% | 2391 |
|
|
2025
Q2 | $19.5M | Sell |
1,602,443
-3,790
| -0.2% | -$42.4K | ﹤0.01% | 2835 |
|
|
2025
Q1 | $19.5M | Sell |
1,606,233
-242,722
| -13% | -$3.24M | ﹤0.01% | 2718 |
|
|
2024
Q4 | $23.7M | Sell |
1,848,955
-361,786
| -16% | -$5.35M | ﹤0.01% | 2593 |
|
|
2024
Q3 | $34.3M | Buy |
2,210,741
+117,263
| +6% | +$1.52M | ﹤0.01% | 2227 |
|
|
2024
Q2 | $21.4M | Buy |
2,093,478
+42,291
| +2% | +$431K | ﹤0.01% | 2587 |
|
|
2024
Q1 | $22.7M | Sell |
2,051,187
-15,806
| -0.8% | -$165K | ﹤0.01% | 2552 |
|
|
2023
Q4 | $22.7M | Buy |
2,066,993
+322,545
| +18% | +$2.44M | ﹤0.01% | 2562 |
|
|
2023
Q3 | $11.2M | Sell |
1,744,448
-99,851
| -5% | -$692K | ﹤0.01% | 3020 |
|
|
2023
Q2 | $11.5M | Sell |
1,844,299
-58,187
| -3% | -$358K | ﹤0.01% | 3038 |
|
|
2023
Q1 | $13.5M | Buy |
1,902,486
+159,549
| +9% | +$1.28M | ﹤0.01% | 2860 |
|
|
2022
Q4 | $13.9M | Sell |
1,742,937
-209,553
| -11% | -$1.75M | ﹤0.01% | 2725 |
|
|
2022
Q3 | $15.7M | Buy |
1,952,490
+50,190
| +3% | +$517K | ﹤0.01% | 2462 |
|
|
2022
Q2 | $18.4M | Buy |
1,902,300
+1,251,437
| +192% | +$14.5M | ﹤0.01% | 2385 |
|
|
2022
Q1 | $10.4M | Sell |
650,863
-96,707
| -13% | -$1.58M | ﹤0.01% | 2868 |
|
|
2021
Q4 | $14M | Sell |
747,570
-8,916
| -1% | -$142K | ﹤0.01% | 2548 |
|
|
2021
Q3 | $10.8M | Sell |
756,486
-139,656
| -16% | -$1.8M | ﹤0.01% | 2798 |
|
|
2021
Q2 | $10.8M | Buy |
896,142
+498,233
| +125% | +$5.97M | ﹤0.01% | 2891 |
|
|
2021
Q1 | $3.98M | Buy |
397,909
+116,969
| +42% | +$1.05M | ﹤0.01% | 3648 |
|
|
2020
Q4 | $2.05M | Sell |
280,940
-77,929
| -22% | -$482K | ﹤0.01% | 4139 |
|
|
2020
Q3 | $1.55M | Buy |
358,869
+170,713
| +91% | +$738K | ﹤0.01% | 3884 |
|
|
2020
Q2 | $914K | Sell |
188,156
-3,796
| -2% | -$16K | ﹤0.01% | 4243 |
|
|
2020
Q1 | $816K | Sell |
191,952
-1,140,299
| -86% | -$11.2M | ﹤0.01% | 4095 |
|
|
2019
Q4 | $17.9M | Buy |
1,332,251
+1,155,805
| +655% | +$13.5M | ﹤0.01% | 1763 |
|
|
2019
Q3 | $1.6M | Buy |
176,446
+15,576
| +10% | +$145K | ﹤0.01% | 3978 |
|
|
2019
Q2 | $1.45M | Buy |
160,870
+5,654
| +4% | +$47.6K | ﹤0.01% | 4013 |
|
|
2019
Q1 | $1.29M | Sell |
155,216
-549,241
| -78% | -$5.21M | ﹤0.01% | 3930 |
|
|
2018
Q4 | $5.65M | Buy |
704,457
+588,465
| +507% | +$5.57M | ﹤0.01% | 2755 |
|
|
2018
Q3 | $1.3M | Buy |
115,992
+17,879
| +18% | +$233K | ﹤0.01% | 4330 |
|
|
2018
Q2 | $1.4M | Buy |
98,113
+31,257
| +47% | +$458K | ﹤0.01% | 4384 |
|
|
2018
Q1 | $1.02M | Buy |
66,856
+58,590
| +709% | +$907K | ﹤0.01% | 4530 |
|
|
2017
Q4 | $132K | Buy |
+8,266
| New | +$127K | ﹤0.01% | 5554 |
|
Other funds holding NMRK
ECP
WHG
Morgan Stanley's NMRK Position: Q2 2026 in Review
Morgan Stanley increased its Newmark Group (NMRK) stake by 11% in Q2 2026, buying an estimated $3M and bringing the position to 1,954,295 shares worth $29.5M. The position accounts for ﹤0.01% of the portfolio, ranked #2739.
Morgan Stanley first reported a position in NMRK in Q4 2017 and has held it in 35 quarters since. The position peaked at $34.5M in Q4 2025. 316 funds tracked by Wall St. Rank hold NMRK as of Q2 2026.
- Morgan Stanley held 1,954,295 shares of Newmark Group worth $29.5M as of Q2 2026.
- Morgan Stanley bought 196,773 Newmark Group shares in Q2 2026, an estimated $3M.
- Newmark Group made up ﹤0.01% of Morgan Stanley's portfolio in Q2 2026, its #2739 holding.
- Morgan Stanley first reported a position in Newmark Group in Q4 2017 and has held it in 35 quarters since.
- Morgan Stanley's Newmark Group position peaked at $34.5M in Q4 2025.
- 316 funds tracked by Wall St. Rank held Newmark Group as of Q2 2026.
Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.